3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Prostatic Neoplasms
1
Pitfalls of PET Scan on Pediattic
1
Parkinson Disease
1
Osteosarcoma
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Intraabdominal Infections
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Neuroendocrine
1
Cancer Patients Referred to do PET/CT Study
1
Interventions
Cisplatin
9
Radiotherapy
6
Carboplatin
6
toripalimab
5
pembrolizumab
5
Surgical Procedures, Operative
5
Nivolumab
5
Docetaxel
5
Cetuximab
5
Paclitaxel
4
Drug Therapy
4
Taxes
3
trilaciclib
2
tislelizumab
2
nimotuzumab
2
camrelizumab
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Magnetic Resonance Spectroscopy
2
Injections
2
Cyclophosphamide
2
Blood Specimen Collection
2
130-nm albumin-bound paclitaxel
2
spartalizumab
1
penpulimab
1
fludarabine phosphate
1
fludarabine
1
dexamethasone-(C21-phosphoramide)-(anti-EGFR)
1
dalpiciclib
1
anlotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Squamous Cell Carcinoma of Head and Neck
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT06726512
2024-12-10
qMAP
University Medical Center Groningen
Phase NA
Not yet recruiting
30 enrolled